NESN Stock Analysis: Nestle S.A. | SW
Packaged Foods | SW, Switzerland | Market Cap: 203.951m CHF | 12M Return: 15.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 313M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Nestlé S.A. is a Switzerland-headquartered multinational that manufactures and distributes food, beverage, and nutritional science products across major markets including the United States, Brazil, Mexico, Greater China, the Philippines, India, and Western Europe, with broader international reach. Founded in 1866 and based in Vevey, the company operates a heavily diversified brand portfolio spanning cereals, chocolate and confectionery, coffee, culinary, chilled and frozen foods, dairy, drinks, food service, ice cream, nutrition and health, petcare, water, and plant-based products.
Its brand stable includes globally recognized names such as Nescafé, Nespresso, KitKat, Maggi, Stouffers, and Häagen-Dazs, alongside the Purina petcare franchise and bottled water labels including Perrier, S.Pellegrino, and Nestlé Pure Life. The company also owns nutritional and health-focused brands such as Gerber, Peptamen, Resource, Garden of Life, and Pure Encapsulations. Aimmune Therapeutics operates as a subsidiary, supporting Nestlés nutritional science footprint.
As a mega-cap player in the Consumer Staples sector (GICS sub-industry: Packaged Foods & Meats), Nestlé exemplifies the diversified, branded packaged-goods business model: relying on a wide portfolio of household-name products across multiple categories and geographies to generate recurring revenue, with coffee, petcare, and nutrition often highlighted as core growth engines within the broader staples landscape.
- Cocoa and coffee input costs pressure confectionery margins
- Purina pet care drives above-market organic growth
- Greater China consumer weakness pressures sales volumes
| Net Income: 7.44b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.57 > 1.0 |
| NWC/Revenue: -8.73% < 20% (prev -14.73%; Δ 6.00% < -1%) |
| CFO/TA 0.13 > 3% & CFO 16.4b > Net Income 7.44b |
| Net Debt (56.7b) to EBITDA (16.6b): 3.41 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.57b) vs 12m ago -1.53% < -2% |
| Gross Margin: 45.45% > 18% (prev 46.66%; Δ -1.20% > 0.5%) |
| Asset Turnover: 68.37% > 50% (prev 69.86%; Δ -1.49% > 0%) |
| Interest Coverage Ratio: 7.41 > 6 (EBIT TTM 13.0b / Interest Expense TTM 1.76b) |
| A: -0.06 (Total Current Assets 37.6b - Total Current Liabilities 45.3b) / Total Assets 128b |
| B: 0.46 (Retained Earnings 58.8b / Total Assets 128b) |
| C: 0.10 (EBIT TTM 13.0b / Avg Total Assets 129b) |
| D: 0.30 (Book Value of Equity 29.2b / Total Liabilities 98.9b) |
| Altman-Z'' = 2.09 = BBB |
| DSRI: 1.09 (Receivables 11.3b/10.7b, Revenue 88.4b/90.9b) |
| GMI: 1.03 (GM 46.66% / 45.45%) |
| AQI: 0.93 (AQ_t 0.47 / AQ_t-1 0.50) |
| SGI: 0.97 (Revenue 88.4b / 90.9b) |
| TATA: -0.07 (NI 7.44b - CFO 16.4b) / TA 128b) |
| Beneish M = -3.00 (Cap -4..+1) = A |
As of July 28, 2026, the stock is trading at CHF 80.39 with a total of 3,735,357 shares traded. Over the past week, the price has changed by -6.23%, over one month by -4.64%, over three months by -0.11% and over the past year by +15.71%.
Current recommended Stop Loss: 76.30 (which is 5.1% or 2.1 ATR below the current price).
Nestle S.A. has no consensus analysts rating.
P/E Trailing = 24.548
P/E Forward = 19.7239
P/S = 2.269
P/B = 6.7555
P/EG = 2.3757
Revenue TTM = 88.4b CHF
EBIT TTM = 13.0b CHF
EBITDA TTM = 16.6b CHF
Long Term Debt = 44.0b CHF (from longTermDebt, last fiscal year)
Short Term Debt = 16.3b CHF (from shortTermDebt, last quarter)
Debt = 62.8b CHF (from shortLongTermDebtTotal, last quarter)
Net Debt = 56.7b CHF (calculated: Debt 62.8b - CCE 6.13b)
Enterprise Value = 261b CHF (204b + Debt 62.8b - CCE 6.13b)
Interest Coverage Ratio = 7.41 (Ebit TTM 13.0b / Interest Expense TTM 1.76b)
EV/FCF = 20.82x (Enterprise Value 261b / FCF TTM 12.5b)
FCF Yield = 4.80% (FCF TTM 12.5b / Enterprise Value 261b)
FCF Margin = 14.17% (FCF TTM 12.5b / Revenue TTM 88.4b)
Net Margin = 8.42% (Net Income TTM 7.44b / Revenue TTM 88.4b)
Gross Margin = 45.45% ((Revenue TTM 88.4b - Cost of Revenue TTM 48.2b) / Revenue TTM)
Gross Margin QoQ = 46.37% (prev 44.58%)
Tobins Q-Ratio = 2.03 (Enterprise Value 261b / Total Assets 128b)
Interest Expense / Debt = 2.80% (Interest Expense 1.76b / Debt 62.8b)
Taxrate = 22.88% (2.28b / 9.96b)
NOPAT = 10.0b (EBIT 13.0b * (1 - 22.88%))
Current Ratio = 0.83 (Total Current Assets 37.6b / Total Current Liabilities 45.3b)
Debt / Equity = 2.15 (Debt 62.8b / totalStockholderEquity, last quarter 29.2b)
Debt / EBITDA = 3.41 (Net Debt 56.7b / EBITDA 16.6b)
Debt / FCF = 4.53 (Net Debt 56.7b / FCF TTM 12.5b)
Total Stockholder Equity = 31.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.76% (Net Income 7.44b / Total Assets 128b)
RoE = 23.47% (Net Income TTM 7.44b / Total Stockholder Equity 31.7b)
RoCE = 17.22% (EBIT 13.0b / Capital Employed (Equity 31.7b + L.T.Debt 44.0b))
RoIC = 10.57% (NOPAT 10.0b / Invested Capital 95.0b)
WACC = 4.42% (E(204b)/V(267b) * Re(5.12%) + D(62.8b)/V(267b) * Rd(2.80%) * (1-Tc(0.23)))
Discount Rate = 5.12% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.67 | Cagr: -3.44%
[DCF] Terminal Value 77.97% ; FCFF base≈11.2b ; Y1≈12.9b ; Y5≈19.0b
[DCF] Fair Price = 88.97 (EV 286b - Net Debt 56.7b = Equity 229b / Shares 2.57b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 39.99 | EPS CAGR: 13.68% | SUE: N/A | # QB: 0
Revenue Correlation: -98.74 | Revenue CAGR: -2.06% | SUE: 1.07 | # QB: 1
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=4.44 | Chg30d=+0.76% | Revisions=+70% | GrowthEPS=+0.4% | GrowthRev=-0.3%
EPS next Year (2027-12-31): EPS=4.74 | Chg30d=+0.94% | Revisions=+55% | GrowthEPS=+6.8% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: +72% (up=14, down=1)